Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by Engcan77on Sep 19, 2019 8:05pm
131 Views
Post# 30145732

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stock looks weak

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Stock looks weakWhen a few months ago i said we could be potentially looking at a $10+ share price, i don't think i was being outrageous. Some may think otherwise. With buybacks of shares, and the continuation of the pipelines. Plus what's up in Q4!! We are looking at lot of million$ of upfront payments,milestone payments and on-going revenue. Nasdaq in sites?
R+F is worth alot of cash, and has the 'know how' and reputation that is huge for Sirona!! Yes,don't underestimate this partnership. They will make a many millions together,combining the science, different products,marketing and sales. What potential!!!!!
Then other partners will just be icing on the cake :) Wanbang in China with diabetes is nothing to sneeze at. Potential partners in China and the rest of the world will be looking even closer at Sirona's science. 
Bullboard Posts